Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication
APLLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Alembic Pharmaceuticals has published newspaper notices informing shareholders about the mandatory transfer of shares to the Investor Education and Protection Fund (IEPF) for those who have not claimed dividends for seven consecutive years or more. The company has already communicated individually with affected shareholders and uploaded their details (names, folio numbers, DP ID client IDs) on its website. Shareholders have until 10th August 2026 to claim their unclaimed dividends before their shares are transferred to the IEPF Demat Account. Both physical and electronic share certificates will be cancelled or transferred accordingly. Shareholders can still reclaim their dividends and shares from IEPF Authority by filing IEPF-5 web form.
This is a routine regulatory compliance filing with no direct impact on the company's operations or stock price. It primarily affects inactive shareholders who may lose ownership of their unclaimed shares to IEPF if they do not respond by the deadline.